Clinical trial
Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal…
NCT00099008 · UNC Lineberger Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00099008 |
|---|---|
| Title | Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women |
| Official title | Phase I Multiple Dose Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women |
| Lead sponsor | UNC Lineberger Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Endometrial Cancer |
| Intervention type | Dietary Supplement |
| Interventions | Genistein, Placebo |
| Enrollment | 30 |
| Start date | Mar 1, 2004 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Dec 9, 2004 |
| Last update posted | May 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: